Showing results (191-200 of 204) with videos related to

Sort By:
Pageof 21
Anticancer Research|May 1, 1990
Differential effects of human natural interferon-alpha and mismatched double-stranded RNA against a human renal cell carcinoma xenograftH R Hubbell, E C Pequignot, K R Shanabrook, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|October 26, 1999
Occupational exposures to blood among emergency medicine residentsC H Lee, W A Carter, W K Chiang, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|October 26, 1999
Tuberculosis exposure risk in emergency medicine residentsA W Asimos, J S Kaufman, C H Lee, et al.
Biochemistry|October 3, 1978
Interferon induction and its dependence on the primary and secondary structure of poly(inosinic acid).poly(cytidylic acid)J J Greene, J L Alderfer, I Tazawa, et al.
Journal of Biological Response Modifiers|October 1, 1987
Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograftH R Hubbell, E C Pequignot, J Todd, et al.
Cancer Letters|September 1, 1979
Purified human fibroblast interferon in vivo: skin reactions and effect on bone marrow precursor cellsW A Carter, J G Dolen, S S Leong, et al.
The Journal of Biological Chemistry|August 22, 2001
Interferon-kappa, a novel type I interferon expressed in human keratinocytesD W LaFleur, B Nardelli, T Tsareva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1994
A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndromeD R Strayer, W A Carter, I Brodsky, et al.
Cancer Treatment Reports|November 1, 1978
Human fibroblast interferon in human neoplasia: clinical and laboratory studyJ S Horoszewicz, S S Leong, M Ito, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograftH R Hubbell, H E Vargas, K L Tsujimoto, et al.
Pageof 21